About ATNM

Actinium Pharmaceuticals, Inc. is a New York, NY based biopharmaceutical company that develops innovative alpha particle immunotherapeutics based on its proprietary platform for the therapeutic utilization of alpha particle emitting actinium-225 and bismuth-213 radiopharmaceuticals in association with monoclonal antibodies.
Primary Exchange: AMEX
SIC Pharmaceutical Preparations
NAICS Pharmaceutical Preparation Manufacturing

ATNM is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
ITOT iShares Core S&P Total U.S. Stock Market ETF 17.1 B 1.71358E+10 3,358 3358 0.0% 0 12 K 12024

Wait, Before You Leave...